Amira Gepstein

Haifa, HA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Utilizing Human-Induced Pluripotent Stem Cells to Study Cardiac Electroporation Pulsed-Field Ablation.

Utilizing Human-Induced Pluripotent Stem Cells to Study Cardiac Electroporation Pulsed-Field Ablation.

Journal: Circulation. Arrhythmia and electrophysiology

Published: February 12, 2024

Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models.

Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models.

Journal: Journal of the American Heart Association

Published: February 03, 2022

Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling.

Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling.

Journal: Physiological reports

Published: January 20, 2022

Using Decellularization/Recellularization Processes to Prepare Liver and Cardiac Engineered Tissues.

Using Decellularization/Recellularization Processes to Prepare Liver and Cardiac Engineered Tissues.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: February 19, 2021

Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes.

Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes.

Journal: JCI insight

Published: January 07, 2021

Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.

Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.

Journal: Acta biomaterialia

Published: October 09, 2018

Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.

Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.

Journal: Journal of the American College of Cardiology

Published: June 27, 2018

Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies.

Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies.

Journal: Stem cell reports

Published: August 03, 2017

Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.

Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.

Journal: Circulation. Arrhythmia and electrophysiology

Published: October 03, 2016

Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters.

Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters.

Journal: Stem cell reports

Published: February 03, 2015

Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.

Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.

Journal: Circulation. Cardiovascular genetics

Published: November 09, 2013

Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.

Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.

Journal: European heart journal

Published: May 25, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026